In the Journals

Evidence lacking for comparative effectiveness, safety of skin cancer treatments

September 17, 2018
A review published in Annals of Internal Medicine found that although several treatment methods for basal cell carcinoma, including surgery, external…

Feature

US military personnel may be at increased risk for skin cancer

August 14, 2018
Active duty military members and veterans in the United States appear to be at elevated risk for melanoma and nonmelanoma skin cancers, according to…

Feature

PD-1 blockade provides ‘dramatic advance’ for the treatment of advanced melanoma

August 13, 2018
Immunotherapy agents — including ipilimumab, nivolumab and pembrolizumab — have changed the landscape of the treatment of advanced…

Penn dermatologist receives award for skin cancer research

August 12, 2018
B rian C. Capell , MD, PhD, received a Damon Runyon Clinical Investigator Award. Capell will use the $450,000 research…

In the JournalsPerspective

Regular sunscreen use lowers melanoma risk among young adults

August 2, 2018
Regular use of sunscreen appeared associated with a reduced risk for melanoma among young adults in Australia, according to findings published in…

In the Journals

Adverse skin reactions can occur months after anti-PD-1 treatment

July 18, 2018
Adverse skin reactions to anti-PD-1 therapy for cancer treatment can occur months after therapy initiation and even after patients discontinue…

In the JournalsPerspective

Tanning bed users more likely to examine skin for cancer

July 3, 2018
People who used indoor tanning beds appeared more likely to check their skin for signs of cancer than those who did not tan, according to a research…

FDA NewsVideo

VIDEO: BRAF-MEK combination represents ‘important new therapy’ for melanoma

June 27, 2018
Victor Sandor, MD, chief medical officer of Array Biopharma, spoke with HemOnc Today about the FDA’s approval of a two-drug combination for a…

FDA News

FDA approves Braftovi-Mektovi combination for BRAF-mutated melanoma

June 27, 2018
The FDA approved the combination of encorafenib and binimetinib for the treatment of patients with unresectable or metastatic melanoma with a…

Feature

Survivin may be target for immunotherapies in several malignancies

June 27, 2018
Survivin, an inhibitor of apoptosis protein, may be an attractive target for a variety of immunotherapeutic approaches for cancer, according to study…

Meeting NewsVideo

VIDEO: Cemiplimab demonstrates ‘impressive activity’ for metastatic cutaneous squamous cell carcinoma

June 19, 2018
CHICAGO — Danny Rischin, MBBS, FRACP, MD, director of the division of cancer medicine and head of the medical oncology department at Peter…

FDA News

FDA clears Paxman scalp-cooling system for all patients with solid tumors

June 11, 2018
The FDA granted expanded clearance to the Paxman Scalp Cooling System, allowing the device to be used by patients with any type of solid tumor. The…

In the Journals

Artificial intelligence superior to dermatologists for melanoma detection

May 29, 2018
A form of artificial intelligence known as a deep learning convolutional neural network appeared more effective than experienced dermatologists for…

In the Journals

Hydrochlorothiazide use may increase melanoma risk

May 29, 2018
Patients classified as high users of hydrochlorothiazide had a higher risk for melanoma, according to findings published in JAMA Internal

Meeting News

Rheumatic adverse effects of immune checkpoint therapy 'poorly recognized' in studies

May 22, 2018
DESTIN, Fla. — Although the incidence of rheumatologic adverse effects associated with immune checkpoint inhibitors is expected to grow with…

FDA News

FDA approves Tafinlar-Mekinist combination for adjuvant treatment of BRAF-mutant melanoma

April 30, 2018
The FDA approved the combination of dabrafenib and trametinib for adjuvant treatment of patients with BRAF V600E- or BRAF V600K-positive melanoma…

FDA News

FDA grants priority review to cemiplimab for advanced cutaneous squamous cell carcinoma

April 30, 2018
The FDA granted priority review to cemiplimab for the treatment of patients with metastatic cutaneous squamous cell carcinoma or those with locally…

In the Journals

World Trade Center responders may face increased cancer burden, elevated myeloma risk

April 26, 2018
Rescue and recovery workers who responded to the World Trade Center site after 9/11 will experience a greater cancer burden over the next 20 years…

In the Journals

Married patients more likely to find melanoma earlier

April 20, 2018
Married patients with melanoma appeared more likely to present with early-stage disease than divorced, widowed or never-married patients, according…

Feature

Obesity may extend survival for men with metastatic melanoma

April 3, 2018
Obesity appeared associated with improved survival among men with metastatic melanoma who underwent treatment with targeted therapy or immunotherapy…

Healio Jobs